<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6323977</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gky1032</article-id>
    <article-id pub-id-type="publisher-id">gky1032</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Human Disease Ontology 2018 update: classification, content and workflow expansion</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8910-9851</contrib-id>
        <name>
          <surname>Schriml</surname>
          <given-names>Lynn M</given-names>
        </name>
        <!--<email>lschriml@som.umaryland.edu</email>-->
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="corresp" rid="COR1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mitraka</surname>
          <given-names>Elvira</given-names>
        </name>
        <xref ref-type="aff" rid="AFF2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Munro</surname>
          <given-names>James</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tauber</surname>
          <given-names>Becky</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schor</surname>
          <given-names>Mike</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Nickle</surname>
          <given-names>Lance</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Felix</surname>
          <given-names>Victor</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jeng</surname>
          <given-names>Linda</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bearer</surname>
          <given-names>Cynthia</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lichenstein</surname>
          <given-names>Richard</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bisordi</surname>
          <given-names>Katharine</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Campion</surname>
          <given-names>Nicole</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hyman</surname>
          <given-names>Brooke</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kurland</surname>
          <given-names>David</given-names>
        </name>
        <xref ref-type="aff" rid="AFF4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Oates</surname>
          <given-names>Connor Patrick</given-names>
        </name>
        <xref ref-type="aff" rid="AFF5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kibbey</surname>
          <given-names>Siobhan</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sreekumar</surname>
          <given-names>Poorna</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Le</surname>
          <given-names>Chris</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Giglio</surname>
          <given-names>Michelle</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Greene</surname>
          <given-names>Carol</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
    </contrib-group>
    <aff id="AFF1"><label>1</label>University of Maryland School of Medicine, Institute for Genome Sciences, Baltimore, MD, USA</aff>
    <aff id="AFF2"><label>2</label>Dalhousie University, Halifax, NS, Canada</aff>
    <aff id="AFF3"><label>3</label>University of Maryland School of Medicine, Baltimore, MD, USA</aff>
    <aff id="AFF4"><label>4</label>New York University Langone Medical Center, Department of Neurosurgery, New York, NY, USA</aff>
    <aff id="AFF5"><label>5</label>Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA</aff>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 401 706 6776; Fax: +1 410 706 6756; Email: <email>lschriml@som.umaryland.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>08</day>
      <month>1</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2018-11-08">
      <day>08</day>
      <month>11</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>08</day>
      <month>11</month>
      <year>2018</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>47</volume>
    <issue>Database issue</issue>
    <issue-title>Database issue</issue-title>
    <fpage>D955</fpage>
    <lpage>D962</lpage>
    <history>
      <date date-type="accepted">
        <day>22</day>
        <month>10</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>04</day>
        <month>10</month>
        <year>2018</year>
      </date>
      <date date-type="received">
        <day>13</day>
        <month>9</month>
        <year>2018</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gky1032.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>The Human Disease Ontology (DO) (<ext-link ext-link-type="uri" xlink:href="http://www.disease-ontology.org">http://www.disease-ontology.org</ext-link>), database has undergone significant expansion in the past three years. The DO disease classification includes specific formal semantic rules to express meaningful disease models and has expanded from a single asserted classification to include multiple-inferred mechanistic disease classifications, thus providing novel perspectives on related diseases. Expansion of disease terms, alternative anatomy, cell type and genetic disease classifications and workflow automation highlight the updates for the DO since 2015. The enhanced breadth and depth of the DO’s knowledgebase has expanded the DO’s utility for exploring the multi-etiology of human disease, thus improving the capture and communication of health-related data across biomedical databases, bioinformatics tools, genomic and cancer resources and demonstrated by a 6.6× growth in DO’s user community since 2015. The DO’s continual integration of human disease knowledge, evidenced by the more than 200 SVN/GitHub releases/revisions, since previously reported in our DO 2015 NAR paper, includes the addition of 2650 new disease terms, a 30% increase of textual definitions, and an expanding suite of disease classification hierarchies constructed through defined logical axioms.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">National Human Genome Research Institute</named-content>
          <named-content content-type="funder-identifier">10.13039/100000051</named-content>
        </funding-source>
        <award-id>U41 HG008735-01A1</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="8"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>The rapid growth of biomedical and clinical research in recent decades has begun to reveal novel cellular, molecular and environmental determinants of disease (<xref rid="B1" ref-type="bibr">1–4</xref>). However, the opportunities for discovery and the transcendence of knowledge between research groups can only be realized in conjunction with the development of rigorous, standardized bioinformatics tools. These tools should be capable of addressing specific biomedical data nomenclature and standardization challenges posed by the vast variety of biomedical data resources, such as the 3 924 249 disease-associated articles published in the past three years (1 January 2015–9 October 2018).</p>
    <p>Standardized disease descriptors that are integrated across biomedical, clinical and genomic resources through a common language provide a human readable and machine-interpretable disease corpus. The development of a robust and well-defined ontology is critical for data sharing, effective interpretation of contextual data, rigorous computational analysis and unifying the representation of common and rare diseases. The Human Disease Ontology (DO) (<ext-link ext-link-type="uri" xlink:href="http://www.disease-ontology.org">http://www.disease-ontology.org</ext-link>), established in 2003, includes the breadth of common and rare diseases, organized as a directed acyclic graph (DAG) representing disease etiology classes, both an axiomatized OWL and an OBO formatted ontology (<xref rid="B5" ref-type="bibr">5</xref>). The latest DO release (GitHub, release 45, v2018-09-10) includes 9069 DOID disease terms, with 62% of terms having a textual definition. As the OBO Foundry's (<ext-link ext-link-type="uri" xlink:href="http://www.obofoundry.org">www.obofoundry.org</ext-link>) domain ontology for human diseases, the DO semantically integrates and connected over 46 000 disease and medical vocabulary terms through extensive cross-reference mappings (MeSH, ICD, NCI’s thesaurus, SNOMED and OMIM) (<xref rid="B6" ref-type="bibr">6–10</xref>). The DO’s standardized descriptions of human diseases improves the capture and communication of health-related data across biomedical databases, bioinformatics tools, genomic and cancer resources.</p>
    <p>Defining diseases based on their anatomical location has long been the standard clinical method for classification utilized in medical textbooks (<xref rid="B11" ref-type="bibr">11</xref>). However, as knowledge of infectious agents, clinical genetics and cellular processes grew in the past 50 years, the need arose for the classification of disease to expand to include, where known, the etiological agents of disease. The heterogeneity of genetic diseases and the multi-organ, multi-cellular origin of cancers further challenges the ontological representation of complex clinical knowledge. Alternate, inferred disease classifications provide related, unique views of related diseases and provide a novel perspective to further our understandings of commonalities of diseases located in a common anatomical location, originating from a particular cell type or resulting from a common genetic mechanism. Cancers are traditionally classified based on pathologic criteria associated with the tumor's tissue of origin. However, the identification of pathological mutations through molecular-based methods has revealed the potential of novel molecular or immunotherapy strategies for cancer treatment (<xref rid="B12" ref-type="bibr">12–17</xref>). Additionally, cell of origin is a promising novel mechanism for identifying molecularly related cancer types (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>). Therefore, expanding how we define cancer molecular subtypes within a cancer molecular taxonomy is essential for advancing translational cancer research and for discerning the contribution of multiple factors towards disease initiation, progression and treatment efficacy (<xref rid="B20" ref-type="bibr">20–21</xref>). Although the body of knowledge regarding the cellular, genetic and environmental basis of disease continues to grow, significant gaps remain in our understanding of mechanistic pathways linking cancer subtypes to environmental triggers and underlying genetic and cellular mechanisms. Consequently, advancements in cancer genomics research are impeded. Therefore, use of semantic standards (biomedical ontologies) will address this challenge and potentially reveal novel therapeutic strategies.</p>
  </sec>
  <sec id="SEC2">
    <title>DO’s CONTENT, WORKFLOW AND DISEASE CLASSIFICATION EXPANSION</title>
    <p>Here, we report on the significant improvements and advances to the DO database since 2015 including a broadening of the DO license, expansion of disease terms, cross reference and logical definition content, automation of data loading and quality control (QC) methods, and development of multiple, alternative disease classifications.</p>
    <p>The DO website content has been maintained with periodic data updates of the DO’s regular data releases, augmented with new DO publications and update announcements via the DO News items (Home page), augmented with new Resources and Downloads content, and expanded search capabilities with the addition of Boolean Advanced searches (Figure <xref ref-type="fig" rid="F1">1</xref>), thus enabling more sophisticated querying across DO definitions, Xrefs, disease names and subsets. This query functionality enables searches that includes one or more search variables, such as the intersection of DO records that contain both OMIM and NCI thesaurus Xrefs (<italic>N</italic> = 738). A direct link to a DO term has been established, this query URL: <ext-link ext-link-type="uri" xlink:href="http://www.disease-ontology.org/?id=DOID:12365">http://www.disease-ontology.org/?id=DOID:12365</ext-link>, allows for term information to be displayed directly in the content panel, while also expanding the ontology tree to show the specific term. The DO website has seen a steady increase in usage, for example with 1.8K to 2.3K users representing 3–3.9K sessions per month (January–August 2018, Google Analytics).</p>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Advanced Boolean Searches. AND/OR searches of any of the DO datatypes (Name, Synonym, Definition, SubSet, DOID, Alternate ID, Xrefs) enable complex data queries of the DO Knowledgebase. For example, a search of Xrefs: OMIM, Name: Parkinson, Subset: DO_rare_slim – identifies all DO disease terms that include a cross-reference (Xref) to OMIM, where the disease name includes ‘Parkinson’ and where the disease is included in the DO_rare_slim – rare disease category. This query in DO, returns seven disease terms.</p>
      </caption>
      <graphic xlink:href="gky1032fig1"/>
    </fig>
    <sec id="SEC2-1">
      <title>DO licensing</title>
      <p>The DO project's data content Creative Commons licensing has been updated from CC BY 3.0 (Attribution) to CC0 (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">https://creativecommons.org/publicdomain/zero/1.0/</ext-link>) (the most open license), as of 5 April 2017, to enhance collaboration and data sharing and to encourage broad and open usage. The DO’s CC0 licensing enables the free distribution of the content of the resource thus enabling open sharing, use, and expansion (derivative works) of the content. The DO project encourages users to cite the DO project's publication, to display DOID identifiers and to link their disease terms back to the DO website. The DO was created to be a community resource, thus open content licensing is the most appropriate license for this project. Classification of human diseases is a complex endeavor, one that is best approached in an open, collaborative and community-data-driven environment.</p>
    </sec>
    <sec id="SEC2-2">
      <title>DO’s production environment</title>
      <p>The DO’s production environment has moved from SourceForge/SVN to GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology">https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology</ext-link>) (November, 2015), with day-to-day editing of DO’s editing file (doid-edit.owl) and the production of single or multi-parent OWL and OBO formatted DO ontology files (with or without inferred parents), DO subsets and customized ontology import files. As outlined in the DO’s GitHub README_DO_Files (<ext-link ext-link-type="uri" xlink:href="https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/src/ontology/README_DO_Files">https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/src/ontology/README_DO_Files</ext-link>), the DO releases includes the production of four sets (OWL and OBO) of DO files, including custom files (created upon request). New term requests, general questions or issues are submitted to the DO team via the DO’s GitHub Issue Tracker (<ext-link ext-link-type="uri" xlink:href="https://github.com/DiseaseOntology/HumanDiseaseOntology/issues">https://github.com/DiseaseOntology/HumanDiseaseOntology/issues</ext-link>). Since moving to GitHub, the DO team has received over 500 GitHub requests for new disease terms, modification or expansion of DO terms, suggestions, topics for review, specific SPARQL queries (e.g. DO terms for all mental health disorders) and assistance with research projects. Resolution of open tickets is an ongoing daily activity of the DO project.</p>
    </sec>
    <sec id="SEC2-3">
      <title>DO files &amp; term counts</title>
      <p>Class counts differs across the DO’s release files, depending on whether the file include obsolete DO terms and the imported ontology terms, as outlined in Table <xref rid="tbl1" ref-type="table">1</xref>. The DO’s GitHub repository includes additional resources, such as a set of SPARQL queries (Figure <xref ref-type="fig" rid="F2">2</xref>) utilized for assessing (QC) the content and quality of the files produced. Additionally, the SPARQL queries are provided to enable DO users to explore DO content in a novel way.</p>
      <table-wrap id="tbl1" orientation="portrait" position="float">
        <label>Table 1.</label>
        <caption>
          <p>DO file names and content, class counts</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">File name (.owl and .obo)</th>
              <th rowspan="1" colspan="1">Content</th>
              <th rowspan="1" colspan="1">Hierarchy</th>
              <th rowspan="1" colspan="1">Classes</th>
              <th rowspan="1" colspan="1">Total # classes</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">doid</td>
              <td rowspan="1" colspan="1">OBO Foundry format</td>
              <td rowspan="1" colspan="1">asserted is_a with, Equivalent To Axioms, SubClass Of Statements</td>
              <td rowspan="1" colspan="1">imports, DOIDs</td>
              <td rowspan="1" colspan="1">17,579</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">doid-non-classified</td>
              <td rowspan="1" colspan="1">DO file format</td>
              <td rowspan="1" colspan="1">asserted is_a</td>
              <td rowspan="1" colspan="1">DOIDs: non-obsolete (9,069)</td>
              <td rowspan="1" colspan="1">11,463</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">doid-merged</td>
              <td rowspan="1" colspan="1">MGI custom file</td>
              <td rowspan="1" colspan="1">asserted is_a, inferred parents</td>
              <td rowspan="1" colspan="1">imports, DOIDs, omim_susceptibility</td>
              <td rowspan="1" colspan="1">15,183</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="T1TFN1">
            <p>Note: The file, doid-non-classified, is an equivalent file (in content and structure) to HumanDO.obo. The DO project has continued to produce the HumanDO files, as this was the original naming convention used by the project for ∼10 years and was included in several publications. Total class counts include non-obsolete and obsolete DOIDs (DO identifiers). OBO Foundry (<ext-link ext-link-type="uri" xlink:href="http://www.obofoundry.org">http://www.obofoundry.org</ext-link>) (<xref rid="B22" ref-type="bibr">22</xref>). For DO’s GitHub release # 45, there are 9,069 DOIDs, also retrievable from the DO’s website.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <fig id="F2" orientation="portrait" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>An example DO SPARQL: doid-report.rq.</p>
        </caption>
        <graphic xlink:href="gky1032fig2"/>
      </fig>
      <p>The DO’s growing library of SPARQL code, verification (QC) and reporting (metrics) includes:</p>
      <p>  QC: dnc-verity-connectivity.rq: Ensure all classes are a subclass of disease</p>
      <p>   dnc-verify-single-parent.rq: Ensure that classes have exactly one parent</p>
      <p>   verify-no-orphans.rq: Ensure that no class is orphaned (excluding top level ‘disease’)</p>
      <p> reporting: xref-report.rq: Return a count of Xrefs on non-obsolete classes</p>
      <p>   import-report.rq: Return a count of each import</p>
      <p>   logical-report.rq: Return a count of logical definitions</p>
      <p>   <bold>doid-report.rq: # Return a count of non-obsolete classes</bold></p>
      <p>   def-port.rq: # Return a count of classes with definitions</p>
      <p>   DO_no_defs.rq: identify set of DO terms needing a textual definition</p>
      <p>A set of 12 customized import files, that represent subsets of other OBO Foundry ontologies are produced with each release (<ext-link ext-link-type="uri" xlink:href="https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology/imports">https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology/imports</ext-link>) along with OWL and OBO formatted DO subset files (slims) that represent a selected set of DO terms as a smaller version of the entire DO file. For the subsets, the OBO versions only contain DO terms, the OWL versions also contain the associated logical axioms (<ext-link ext-link-type="uri" xlink:href="https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology/subsets">https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology/subsets</ext-link>). These customized DO slim files include: AGR (Alliance for Genome Resources) (<ext-link ext-link-type="uri" xlink:href="https://www.alliancegenome.org">https://www.alliancegenome.org</ext-link>), FlyBase (<xref rid="B23" ref-type="bibr">23</xref>), MGI, cancer, rare disease and NCI thesaurus, are used to annotate cancer variants, animal models and human genes to human diseases, rather than using the full DO. The NCI thesaurus subset was expanded in August 2018 to include all NCI thesaurus terms in the DO (4302 terms).</p>
    </sec>
    <sec id="SEC2-4">
      <title>DO content update</title>
      <sec id="SEC2-4-1">
        <title>Term expansion</title>
        <p>The latest release of the DO [release 45; GitHub release v2018-09-10], with 9069 ‘non-obsolete’ classes (disease terms), represents an increase of 2650 disease terms, with 62% (5642/9069) of DO terms defined with a textual definition, since 2015. The new disease terms have been added across the DO, in particular expanding the structure of DO’s hematopoietic, neurodegenerative, inherited metabolic disorders and genetic diseases (Figure <xref ref-type="fig" rid="F3">3</xref>). Human disease knowledge is continually integrated into the DO, as evidenced by the 190 SourceForge revisions (from revision 2702 on 6 October 2014 to revision 2895 on 11 March 2016) and 45 GitHub releases (March 2016–September 2018) since 2015. The legacy DO SourceForge repository will be retired by the end of 2018.</p>
        <fig id="F3" orientation="portrait" position="float">
          <label>Figure 3.</label>
          <caption>
            <p>Example areas of term expansion: (<bold>A</bold>) hematopoietic system diseases and (<bold>B</bold>) inherited metabolic disorders. Blue arrow indicates new DO terms.</p>
          </caption>
          <graphic xlink:href="gky1032fig3"/>
        </fig>
      </sec>
      <sec id="SEC2-4-2">
        <title>Automated workflows</title>
        <p>Various parts of the DO workflow have been automated using the ROBOT command line tool (<ext-link ext-link-type="uri" xlink:href="http://robot.obolibrary.org">http://robot.obolibrary.org</ext-link>). ROBOT, developed in Java and available open source on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/ontodev/robot">https://github.com/ontodev/robot</ext-link>), has also been implemented in other OBO Foundry ontologies such as the Ontology for Biomedical Investigations (<xref rid="B24" ref-type="bibr">24</xref>), the Gene Ontology (<xref rid="B25" ref-type="bibr">25</xref>), the Evidence and Conclusion (ECO) ontology (<xref rid="B26" ref-type="bibr">26</xref>) and the Immune Epitope Database's (IEDB) (<xref rid="B27" ref-type="bibr">27</xref>) MHC Restriction Ontology (<xref rid="B28" ref-type="bibr">28</xref>, <ext-link ext-link-type="uri" xlink:href="http://ceur-ws.org/Vol-1515/demo6.pdf">http://ceur-ws.org/Vol-1515/demo6.pdf</ext-link>). ROBOT allows developers to quickly integrate logical definitions and class annotations through the ‘template’ command, which transforms a spreadsheet into OWL axioms. New content is added to the DO from structured ROBOT template spreadsheets that include rows of new content with columns for the DOID, disease name, definition, definition Xref, parent DOID, synonyms and logical axioms. The ROBOT template spreadsheet is organized by the first two rows, to specify the ROBOT terms (e.g. Label) and corresponding ontology terms (e.g. A rdfs:label) for the disease name. Introducing ROBOT templates to the DO production pipeline has enabled the DO team and collaborators (such as Mouse Genome Informatics (MGI) (<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>), Rat Genome Database (RGD) (<xref rid="B31" ref-type="bibr">31</xref>), IEDB and Wikidata (<xref rid="B32" ref-type="bibr">32</xref>) to coordinate data updates and additions through shared Google spreadsheets. Following thorough quality control and validation, the new axioms are programmatically added to DO, thus greatly reducing the time for data integration and improving overall data quality.</p>
        <p>Some of the content that has been recently added to DO using ROBOT templates includes:
<list list-type="bullet"><list-item><p>rare cancers from Clinical Interpretation of Variants in Cancer (CIViC) (<xref rid="B33" ref-type="bibr">33</xref>), this work has enhanced DO’s content, for clinically actionable cancer variants, as represented in literature, and defined in the CIViC database.</p></list-item><list-item><p>140 new allergy diseases from IEDB and related logical definitions linking classes to UBERON (anatomy), FoodOn (food allergic triggers), ChEBI (chemical allergic triggers), and NCBITaxon (<xref rid="B34" ref-type="bibr">34–37</xref>).</p></list-item><list-item><p>43 new human diseases from MGI complete with cross references, synonyms, textual definitions, and parent classes.</p></list-item><list-item><p>50 OMIM, 1491 GARD (rare disease) (<xref rid="B38" ref-type="bibr">38</xref>) and 655 MeSH cross references identified by Wikidata users, extracted from Wikidata database and validated by the DO team.</p></list-item><list-item><p>1433 textual definitions added to existing DO classes to enrich the DO’s cancer classification, constructed by seven second to fourth year University of Maryland School of Medicine medical students.</p></list-item><list-item><p>OMIM splits: new DO terms for genetic disease subtypes: curated by MGI—(469 new DO terms) and RGD (201 new DO terms). This is an ongoing, weekly activity as new terms are created in OMIM, curated by MGI, RGD and DO, then added to DO. This work has resulted in a vast expansion of genetic diseases, and their associated OMIM IDs in the DO, contributing significantly to the DO’s ongoing focus with MGI and RGD to represent OMIM’s Phenotypic series (90 OMIM:PS# in DO, and 3273 OMIM ID Xrefs) as disease subtypes.</p></list-item></list></p>
        <p>Adding new subtypes to the DO, as defined by the OMIM Phenotypic Series, is an ongoing curation task for the DO team. The DO parent term, e.g. primary hypomagnesemia [DOID:0060879] is annotated with the OMIM Phenotype Series ID (e.g. PS602014), if it has been defined by OMIM. The set of OMIM phenotypes define the new DO terms, one OMIM ID per DO term. As the Phenotypic Series expand, the DO team adds the new DO terms as needed. Given the breadth of the Phenotypic Series and their ongoing development, there can be a time lag between the addition of terms. MGI identifies each week the creation of new OMIM phenotypes, additions to Phenotypic Series or updates to OMIM IDs and coordinates these changes in the DO OMIM curation queue that we jointly maintain.</p>
        <p>ROBOT has also been implemented to automate the entire DO release process. A series of commands are contained in a ‘Makefile’ which automatically builds target products (DO’s production OWL and OBO files, slims, subsets) in under 10 minutes. This process includes a series of customizable ontology error and warning checks (e.g. white spaces, duplicate synonym, multiple asserted superclasses, invalid Xref, missing obsolete label) produced from the ROBOT ‘report’ command, which identifies areas of improvement for the ontology file as curation QC output files. The ROBOT release process has also integrated a series of time-intensive, manual file checks (e.g. dates, versioning). Additionally, the ROBOT tool's commands are utilized to update import ontologies, remove and filter parts of the DO to create subsets, and annotate final release files.</p>
      </sec>
    </sec>
    <sec id="SEC2-6">
      <title>To etiology and beyond—disease classifications</title>
      <p>The DO’s classification expansion is evolving through a structured, step-wise approach with the goal of representing DO diseases through multiple-inferred classifications. The classifications are encoded within the DO’s OWL files, defined by Equivalent To axioms and SubClass Of statements, queryable and viewable at the EBI’s Ontology Lookup Service (<xref rid="B39" ref-type="bibr">39</xref>), <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ols/ontologies/doid">https://www.ebi.ac.uk/ols/ontologies/doid</ext-link>. To date the DO contains 730 Equivalent To axioms and 3612 SubClass Of statements. The eleven types of axioms (e.g. anatomical, genetic, cell type), being constructed in the DO are defined by a specific RO (Relation Ontology) (<xref rid="B40" ref-type="bibr">40</xref>) term and an OBO Foundry term. For example, a sequence variant axiom could be constructed as ‘has_material_basis_in some (loss_of_function_variant and maternal_uniparental_disomy). The associated OBO Foundry imports have been customized to include the subset of their terms utilized by the DO for defining axioms, thus reducing the overall size of the DO’s OWL files. When a new OBO ontology term is needed, the ROBOT tool is utilized to augment the DO’s imports. Expansion of DO’s inferred classifications allows users to examine related diseases from multiple perspectives. For example, logical definitions for two skin diseases, ichthyosis and autosomal dominant cutis laxa (Figure <xref ref-type="fig" rid="F4">4</xref>), demonstrates.</p>
      <p>To date, logical axioms for the DO’s inferred-anatomy classification are complete, DO’s inferred-cell type and inferred-genetic classifications are in progress. To rigorously build the DO inferred-classifications, the follow protocol has been established, with DO’s inferred-anatomy classification as an example: scripted identification of anatomy terms (e.g. heart, pericardium, artery, vein, cardiac, aortic) utilized for each branch of DO’s ‘disease of anatomical entity’ branch to:
<list list-type="order"><list-item><p>define Equivalent To axioms for parent terms, for example, for the ‘cardiovascular system disease’ branch, Equivalent To: ‘disease and located_in some cardiovascular system’;</p></list-item><list-item><p>search the entirety of DO to identify other diseases that were likewise located_in one of the anatomical locations (outside of the ‘disease of anatomical entity’);</p></list-item><list-item><p>define SubClass Of statements for disease terms we want to define as an inferred child of ‘cardiovascular system disease’, such as ‘autoimmune cardiomyopathy’ with the SubClass Of statement: ‘located_in some heart’;</p></list-item><list-item><p>The DO has expanded anatomical mechanistic models for DO’s 12 ‘disease of anatomical entity’ branches and 14 organ system cancer branches and is in the process of defining cell of origin models for DO’s 11 cell type cancer branches by defining the most granular anatomical location and cell of origin SubClass Of statements for each cancer type using the ‘located_in’ and ‘has_material_basis_in’ relationships.</p></list-item></list></p>
      <fig id="F4" orientation="portrait" position="float">
        <label>Figure 4.</label>
        <caption>
          <p>Skin disease logical axioms, define inferred disease parents. Integration of a SubClass Of logical axiom for ‘ichthyosis vulgaris’ and ‘autosomal dominant cutis laxa’ [BOLD] (‘has material basis in’ some ‘autosomal dominant inheritance’) and an ‘Equivalent To logical axiom for ‘autosomal dominant disease’ (disease and (‘has material basis in’ some ‘autosomal dominant inheritance’)), where ‘autosomal dominant inheritance is from the Genotype Ontology (<ext-link ext-link-type="uri" xlink:href="http://www.obofoundry.org/ontology/geno.html">http://www.obofoundry.org/ontology/geno.html</ext-link>) creates ‘inferred’ child to parent DO relationships, thus both skin diseases are defined as inferred child terms of DO’s ‘autosomal dominant disease’.</p>
        </caption>
        <graphic xlink:href="gky1032fig4"/>
      </fig>
      <p>Further models will be defined for DO’s pre-malignant neoplasm and benign neoplasm terms. The tissue and cell of origin axioms (logical definitions) enable querying and enhanced views of the DO with logical definitions associated with OBO Foundry ontologies), UBERON (anatomy) and the Cell Ontology (cell types) (<xref rid="B41" ref-type="bibr">41</xref>). The expansion DO’s mechanistic classifications for DO’s organ system and cell type cancers are producing multi-mechanistic cancer models. These novel models of cancer will provide a robust backbone for complex cancer queries, exposing a multi-faceted, cancer classification systems in an intuitive format with data managed within a rigorous semantic structure.</p>
    </sec>
    <sec id="SEC2-7">
      <title>DO user community expansion &amp; metrics</title>
      <p>The DO user community has continued to expand over the past three years, in addition to adoption of the DO by the Model Organism Databases (MOD), DO has been integrated into the Alliance for Genome Resources, thus facilitating gene and allele comparative analysis. For example, the AGR’s query interface presents 34 alleles associated with neurodegenerative diseases (<ext-link ext-link-type="uri" xlink:href="https://www.alliancegenome.org/search?category=allele&amp;diseaseDocuments.name=neurodegenerative%20disease&amp;q=syndrome%5B1%5D%20%28Dme%29">https://www.alliancegenome.org/search?category= allele&amp;diseaseDocuments.name=neurodegenerative%20disease&amp;q=syndrome%5B1%5D%20%28Dme%29</ext-link>). Whereas, a query on a specific disease, e.g. Huntington's disease, returns the 128 AGR gene associations (<ext-link ext-link-type="uri" xlink:href="https://www.alliancegenome.org/disease/DOID:12858#associations">https://www.alliancegenome.org/disease/DOID:12858#associations</ext-link>) from RGD, MGI, ZFIN (<xref rid="B42" ref-type="bibr">42</xref>), FlyBase and WormBase (<xref rid="B43" ref-type="bibr">43</xref>).</p>
      <p>Determining usage of an open-source biomedical resources, such as the DO, is a non-trivial activity, involving direct project citations, mentions of the resource, project URL or unique identifier (e.g. DOID) in PubMed and Google searches. Utilizing this multi-factored approach (on a monthly basis), the DO team has identified a body of 336 DO project citations (as of August 2018), an increase from ∼50 citations in 2015. This set of citations has been compiled as a public PubMed MyNCBI collection (DO_citing_papers: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sites/myncbi/lynn.schriml.1/collections/49204559/public/">https://www.ncbi.nlm.nih.gov/sites/myncbi/lynn.schriml.1/collections/49204559/public/</ext-link>). This MyNCBI collection represents the growing number of instances of integration of DO in databases, research studies, bioinformatics tools.</p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>FUTURE DIRECTIONS</title>
    <p>In the near term, the DO’s website will be getting a face lift, to enhance educational materials, connect to a broader user community, and improve coordination of outreach opportunities. The DO’s website v2.0 is under construction to provide querying of the DO’s inferred classifications (doid.owl file). Keep an eye on the DO’s growing number of inferred-classifications for organ and cell type cancers and genetic diseases, which will be updated with DO’s monthly GitHub releases. The first set of inferred disease classifications will be expanded to include inferred disease classification hierarchies for genetic, inheritance, symptom, phenotype, transmission method and pathogenic agent. For example, observable characteristics or traits (phenotypic traits) from the Human Phenotype Ontology (HPO) (<xref rid="B44" ref-type="bibr">44</xref>) will define logical axioms with the ‘has_phenotype’ relation for phenotypes of syndromes and genetic diseases. A complex etiology-based disease classification is in the early stages of development, for an early preview, query Prader-Willi syndrome at EBI’s Ontology Lookup Service. The DO will continue to grow in content and scope, integrating additional rare diseases, newly published diseases and revising etiology classifications as knowledge evolves. The DO’s team has expanded substantially in the past year. A near term goal for the team is to address the current backlog of GitHub tickets.</p>
  </sec>
  <sec id="SEC4">
    <title>DATA AVAILABILITY</title>
    <p>The Human Disease Ontology content is available, under Creative Commons CC0 (CC0 1.0 Universal) license, in the GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology">https://github.com/DiseaseOntology/HumanDiseaseOntology/tree/master/src/ontology</ext-link>), at the OBO Foundry (<ext-link ext-link-type="uri" xlink:href="http://www.obofoundry.org/ontology/doid.html">http://www.obofoundry.org/ontology/doid.html</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://purl.obolibrary.org/obo/doid.owl">http://purl.obolibrary.org/obo/doid.owl</ext-link>), from the DO’s website (<ext-link ext-link-type="uri" xlink:href="http://www.disease-ontology.org">http://www.disease-ontology.org</ext-link>), and the Ontology Lookup Service (OLS) at EBI (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ols/ontologies/doid">https://www.ebi.ac.uk/ols/ontologies/doid</ext-link>).</p>
  </sec>
</body>
<back>
  <ack>
    <title>ACKNOWLEDGEMENTS</title>
    <p>The authors acknowledge and thank all of the DO’s contributors and collaborators. We strive to incorporate suggestions, corrections and improvements as quickly as possible and appreciate the DO communities significant contributions to the quality and integrity of the DO. In particular, we thank James Overton for ROBOT and your willingness to share ROBOT with the DO project, the generous and ongoing collaborations with MGI and RGD (Sue Bello, Cynthia Smith, Stan Laulederkind, Janan Eppig and Mary Shimoyama), with Randi Vita and Bjoern Peters at IEDB, with the GenEpiO and FoodOn projects, Damion Dooley for contributing DO release quality checks and with our Wikidata collaborators: Andrew Su, Ben Good, Greg Stuppe and Andra Waagmeester, Sebastian Burgstaller and Tim Putman. We thank the army of volunteers at the OBO Foundry.</p>
  </ack>
  <sec id="SEC5">
    <title>FUNDING</title>
    <p>National Institutes of Health–National Human Genome Research Institute (NHGRI) [U41 HG008735-01A1 to L.S.]; NIH-NHGRI U41 [BD2K] Administrative Supplemental [2U41HG000330-28 to J.E., M.G.I.]. Funding for open access charge: NIH/NHGRI [U41 HG008735-01A1].</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toss</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Piacentini</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Cortesi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Artuso</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Bernardis</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Parenti</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tenedini</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ficarra</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Maiorana</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Iannone</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications</article-title>. <source>Oncotarget</source>. <year>2018</year>; <volume>9</volume>:<fpage>31606</fpage>–<lpage>31619</lpage>.<pub-id pub-id-type="pmid">30167082</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><collab>Cancer Target Discovery and Development Network</collab><article-title>Transforming big data into Cancer-Relevant insight: An initial, Multi-Tier approach to assess reproducibility and relevance</article-title>. <source>Mol. Cancer Res.</source><year>2016</year>; <volume>14</volume>:<fpage>675</fpage>–<lpage>682</lpage>.<pub-id pub-id-type="pmid">27401613</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lyles</surname><given-names>C.R.</given-names></name>, <name name-style="western"><surname>Lunn</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Obedin-Maliver</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bibbins-Domingo</surname><given-names>K.</given-names></name></person-group><article-title>The new era of precision population health: insights for the all of us research program and beyond</article-title>. <source>J. Transl. Med.</source><year>2018</year>; <volume>16</volume>:<fpage>211</fpage>.<pub-id pub-id-type="pmid">30053823</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anaya</surname><given-names>J.-M.</given-names></name>, <name name-style="western"><surname>Ramirez-Santana</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Alzate</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Molano-Gonzalez</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Rojas-Villarraga</surname><given-names>A.</given-names></name></person-group><article-title>The autoimmune ecology</article-title>. <source>Front. Immunol.</source><year>2016</year>; <volume>7</volume>:<fpage>139</fpage>.<pub-id pub-id-type="pmid">27199979</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kibbe</surname><given-names>W.A.</given-names></name>, <name name-style="western"><surname>Arze</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Felix</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Mitraka</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bolton</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mungall</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Binder</surname><given-names>J.X.</given-names></name>, <name name-style="western"><surname>Malone</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Vasant</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D1071</fpage>–<lpage>D1078</lpage>.<pub-id pub-id-type="pmid">25348409</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Schopen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Savage</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Schulman</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Arluk</surname><given-names>N.</given-names></name></person-group><article-title>The MeSH translation maintenance system: structure, interface design, and implementation</article-title>. <source>Stud. Health Technol. Inform.</source><year>2004</year>; <volume>107</volume>:<fpage>67</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">15360776</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanno</surname><given-names>L.K.</given-names></name>, <name name-style="western"><surname>Chalmers</surname><given-names>R.J.G.</given-names></name>, <name name-style="western"><surname>Calderon</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Aymé</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Demoly</surname><given-names>P.</given-names></name><collab>on behalf the Joint Allergy Academies</collab></person-group><article-title>Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11)</article-title>. <source>Orphanet J. Rare Dis.</source><year>2017</year>; <volume>12</volume>:<fpage>53</fpage>.<pub-id pub-id-type="pmid">28302183</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Coronado</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>L.W.</given-names></name>, <name name-style="western"><surname>Fragoso</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Haber</surname><given-names>M.W.</given-names></name>, <name name-style="western"><surname>Hahn-Dantona</surname><given-names>E.A.</given-names></name>, <name name-style="western"><surname>Hartel</surname><given-names>F.W.</given-names></name>, <name name-style="western"><surname>Quan</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Safran</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Whiteman</surname><given-names>L.</given-names></name></person-group><article-title>The NCI Thesaurus quality assurance life cycle</article-title>. <source>J. Biomed. Inform.</source><year>2006</year>; <volume>42</volume>:<fpage>530</fpage>–<lpage>539</lpage>.</mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donnelly</surname><given-names>K.</given-names></name></person-group><article-title>SNOMED-CT: the advanced terminology and coding system for eHealth</article-title>. <source>Stud. Health Technol. Inform.</source><year>2006</year>; <volume>121</volume>:<fpage>279</fpage>–<lpage>290</lpage>.<pub-id pub-id-type="pmid">17095826</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amberger</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Bocchini</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Schiettecatte</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>A.F.</given-names></name>, <name name-style="western"><surname>Hamosh</surname><given-names>A.</given-names></name></person-group><article-title>OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D789</fpage>–<lpage>D798</lpage>.<pub-id pub-id-type="pmid">25428349</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kasper</surname><given-names>D.L.</given-names></name>, <name name-style="western"><surname>Braunwald</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fauci</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hauser</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Longo</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Jameson</surname><given-names>J.L.</given-names></name></person-group><source>Harrison's Principles of Internal Medicine</source>. <year>2005</year>; <edition>16th edn</edition><publisher-loc>NY</publisher-loc>: <publisher-name>McGraw-Hill Medical Publishing Division</publisher-name>.</mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venkitachalam</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Revoredo</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Varadan</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Fecteau</surname><given-names>R.E.</given-names></name>, <name name-style="western"><surname>Ravi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Lutterbaugh</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Markowitz</surname><given-names>S.D.</given-names></name>, <name name-style="western"><surname>Willis</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Gerken</surname><given-names>T.A.</given-names></name>, <name name-style="western"><surname>Guda</surname><given-names>K.</given-names></name></person-group><article-title>Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer</article-title>. <source>Sci. Rep.</source><year>2016</year>; <volume>6</volume>:<fpage>23642</fpage>.<pub-id pub-id-type="pmid">27004849</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silwal-Pandit</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Langerød</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Børresen-Dale</surname><given-names>A.L.</given-names></name></person-group><article-title>TP53 mutations in breast and ovarian cancer</article-title>. <source>Cold Spring Harb. Perspect. Med.</source><year>2017</year>; <volume>7</volume>:<fpage>a026252</fpage>.<pub-id pub-id-type="pmid">27815305</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janky</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Binda</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Allemeersch</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Van den Broeck</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Govaere</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Swinnen</surname><given-names>J.V.</given-names></name>, <name name-style="western"><surname>Roskams</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Aerts</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Topal</surname><given-names>B.</given-names></name></person-group><article-title>Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma</article-title>. <source>BMC Cancer</source>. <year>2016</year>; <volume>16</volume>:<fpage>632</fpage>.<pub-id pub-id-type="pmid">27520560</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allain</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Angenard</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Clément</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Coulouarn</surname><given-names>C.</given-names></name></person-group><article-title>Integrative genomic analysis identifies the core transcriptional hallmarks of human hepatocellular carcinoma</article-title>. <source>Cancer Res.</source><year>2016</year>; <volume>76</volume>:<fpage>6374</fpage>–<lpage>6381</lpage>.<pub-id pub-id-type="pmid">27634755</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weber</surname><given-names>A.N.R.</given-names></name>, <name name-style="western"><surname>Cardona</surname><given-names>G.Y.</given-names></name>, <name name-style="western"><surname>Çınar</surname><given-names>Ö.</given-names></name>, <name name-style="western"><surname>Reinhardt</surname><given-names>H.C.</given-names></name>, <name name-style="western"><surname>Pezzutto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wolz</surname><given-names>O.O.</given-names></name></person-group><article-title>Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities</article-title>. <source>Cancer Immunol. Immunother.</source><year>2018</year>; <volume>67</volume>:<fpage>1797</fpage>–<lpage>1807</lpage>.<pub-id pub-id-type="pmid">30203262</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Manfredi</surname><given-names>M.G.</given-names></name>, <name name-style="western"><surname>Zakharia</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Prendergast</surname><given-names>G.C.</given-names></name></person-group><article-title>Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond</article-title>. <source>Semin Immunopathol</source>. <year>2018</year>; <comment>doi:10.1007/s00281-018-0702-0</comment>.</mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoadley</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Yau</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Cherniack</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Tamborero</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Leiserson</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>McLellan</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Uzunangelov</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Multi-platform analysis of 12 cancer types reveals molecular classification within and across tissues-of-origin</article-title>. <source>Cell</source>. <year>2014</year>; <volume>158</volume>:<fpage>929</fpage>–<lpage>944</lpage>.<pub-id pub-id-type="pmid">25109877</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Tokheim</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Porta-Pardo</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Sengupta</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bertrand</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Weerasinghe</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Colaprico</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wendl</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Reardon</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Comprehensive characterization of cancer driver genes and mutations</article-title>. <source>Cell</source>. <year>2018</year>; <volume>174</volume>:<fpage>1034</fpage>–<lpage>1035</lpage>.<pub-id pub-id-type="pmid">30096302</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnitt</surname><given-names>S.J.</given-names></name></person-group><article-title>Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy</article-title>. <source>Mod. Pathol.</source><year>2010</year>; <volume>Suppl. 2</volume>:<fpage>S60</fpage>–<lpage>S64</lpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bastian</surname><given-names>B.C.</given-names></name></person-group><article-title>The molecular pathology of melanoma: An integrated taxonomy of melanocytic neoplasia</article-title>. <source>Annu. Rev. Pathol.</source><year>2014</year>; <volume>9</volume>:<fpage>239</fpage>–<lpage>271</lpage>.<pub-id pub-id-type="pmid">24460190</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ashburner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rosse</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bard</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bug</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ceusters</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Goldberg</surname><given-names>L.J.</given-names></name>, <name name-style="western"><surname>Eilbeck</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ireland</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mungall</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>The OBO foundry: coordinated evolution of ontologies to support biomedical data integration</article-title>. <source>Nat. Biotechnol.</source><year>2007</year>; <volume>25</volume>:<fpage>1251</fpage>.<pub-id pub-id-type="pmid">17989687</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Millburn</surname><given-names>G.H.</given-names></name>, <name name-style="western"><surname>Crosby</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Gramates</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tweedie</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Consortium</surname><given-names>the FlyBase</given-names></name></person-group><article-title>FlyBase portals to human disease research using Drosophila models</article-title>. <source>Dis. Models Mech.</source><year>2016</year>; <volume>9</volume>:<fpage>245</fpage>–<lpage>252</lpage>.</mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bandrowski</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Brinkman</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Brochhausen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brush</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Bug</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Chibucos</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Clancy</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Courtot</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Derom</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Dumontier</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The ontology for biomedical investigations</article-title>. <source>PLoS One</source>. <year>2016</year>; <volume>11</volume>:<fpage>e0154556</fpage>.<pub-id pub-id-type="pmid">27128319</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Consortium</surname><given-names>The Gene Ontology</given-names></name></person-group><article-title>Gene ontology consortium: going forward</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D1049</fpage>–<lpage>D1056</lpage>.<pub-id pub-id-type="pmid">25428369</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chibucos</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Siegele</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Giglio</surname><given-names>M.</given-names></name></person-group><article-title>The evidence and conclusion ontology (ECO): supporting GO annotations</article-title>. <source>Methods Mol. Biol.</source><year>2017</year>; <volume>1446</volume>:<fpage>245</fpage>–<lpage>259</lpage>.<pub-id pub-id-type="pmid">27812948</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vita</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Overton</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Greenbaum</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Ponomarenko</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>J.D.</given-names></name>, <name name-style="western"><surname>Cantrell</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>D.K.</given-names></name>, <name name-style="western"><surname>Gabbard</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Hix</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sette</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>B.</given-names></name></person-group><article-title>The immune epitope database (IEDB) 3.0</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D405</fpage>–<lpage>D412</lpage>.<pub-id pub-id-type="pmid">25300482</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Overton</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Dietze</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Essaid</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Osumi-Sutherland</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Mungall</surname><given-names>C.J.</given-names></name></person-group><article-title>ROBOT: a command-line tool for ontology development</article-title>. <source>ICBO 2015 poster</source>. <year>2015</year>.</mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eppig</surname><given-names>J.T.</given-names></name></person-group><article-title>Mouse genome informatics (MGI) resource: Genetic, genomic, and biological knowledgebase for the laboratory mouse</article-title>. <source>ILAR J.</source><year>2017</year>; <volume>58</volume>:<fpage>17</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">28838066</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bello</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Shimoyama</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mitraka</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Laulederkind</surname><given-names>S.J.F.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Eppig</surname><given-names>J.T.</given-names></name>, <name name-style="western"><surname>Schriml</surname><given-names>L.M.</given-names></name></person-group><article-title>Disease Ontology: improving and unifying disease annotations across species</article-title>. <source>Dis.Models Mech.</source><year>2018</year>; <volume>11</volume>:<comment>doi:10.1242/dmm.032839</comment>.</mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laulederkind</surname><given-names>S.J.F.</given-names></name>, <name name-style="western"><surname>Hayman</surname><given-names>G.T.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Petri</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>De Pons</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tutaj</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Ghiasvand</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Tutaj</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A primer for the rat genome database (RGD)</article-title>. <source>Methods Mol. Biol.</source><year>2018</year>; <volume>1757</volume>:<fpage>163</fpage>–<lpage>209</lpage>.<pub-id pub-id-type="pmid">29761460</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgstaller-Muehlbacher</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Waagmeester</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mitraka</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Putman</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Leong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Naik</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pavlidis</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Schriml</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Good</surname><given-names>B.M.</given-names></name><etal/></person-group><article-title>Wikidata as a semantic framework for the Gene Wiki initiative</article-title>. <source>Database</source>. <year>2016</year>; <volume>2016</volume>:<fpage>baw015</fpage>.<pub-id pub-id-type="pmid">26989148</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffith</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Spies</surname><given-names>N.C.</given-names></name>, <name name-style="western"><surname>Krysiak</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>McMichael</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Coffman</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Danos</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Ainscough</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Ramirez</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Rieke</surname><given-names>D.T.</given-names></name>, <name name-style="western"><surname>Kujan</surname><given-names>L.</given-names></name><etal/></person-group><article-title>CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer</article-title>. <source>Nat. Genet.</source><year>2017</year>; <volume>49</volume>:<fpage>170</fpage>–<lpage>174</lpage>.<pub-id pub-id-type="pmid">28138153</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mungall</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Torniai</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gkoutos</surname><given-names>G.V.</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Haendel</surname><given-names>M.A.</given-names></name></person-group><article-title>Uberon, an integrative multi-species anatomy ontology</article-title>. <source>Genome Biol.</source><year>2012</year>; <volume>13</volume>:<fpage>R5</fpage>.<pub-id pub-id-type="pmid">22293552</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffiths</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Dooley</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Van Domselaar</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Brinkman</surname><given-names>F.S.L.</given-names></name>, <name name-style="western"><surname>Hsiao</surname><given-names>W.W.L.</given-names></name></person-group><article-title>Context is everything: Harmonization of critical food microbiology descriptors and metadata for improved food safety and surveillance</article-title>. <source>Front. Microbiol.</source><year>2017</year>; <volume>8</volume>:<fpage>1068</fpage>.<pub-id pub-id-type="pmid">28694792</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hastings</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>de Matos</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Dekker</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ennis</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Harsha</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kale</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Muthukrishnan</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Owen</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D456</fpage>–<lpage>D463</lpage>.<pub-id pub-id-type="pmid">23180789</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Federhen</surname><given-names>S.</given-names></name></person-group><article-title>The NCBI taxonomy database</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>D136</fpage>–<lpage>D143</lpage>.<pub-id pub-id-type="pmid">22139910</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Snyder</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hyatt-Knorr</surname><given-names>H.</given-names></name></person-group><article-title>Marking 15 years of the genetic and rare diseases information center</article-title>. <source>Transl. Sci. Rare Dis.</source><year>2017</year>; <volume>2</volume>:<fpage>77</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">29152459</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Côté</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Reisinger</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Martens</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Barsnes</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Vizcaino</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Hermjakob</surname><given-names>H.</given-names></name></person-group><article-title>The ontology lookup service: bigger and better</article-title>. <source>Nucleic Acids Res.</source><year>2010</year>; <volume>38</volume>:<fpage>W155</fpage>–<lpage>W160</lpage>.<pub-id pub-id-type="pmid">20460452</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ceusters</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Klagges</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Köhler</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lomax</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mungall</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Neuhaus</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Rector</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Rosse</surname><given-names>C.</given-names></name></person-group><article-title>Relations in biomedical ontologies</article-title>. <source>Genome Biol.</source><year>2005</year>; <volume>6</volume>:<fpage>R46</fpage>.<pub-id pub-id-type="pmid">15892874</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diehl</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Meehan</surname><given-names>T.F.</given-names></name>, <name name-style="western"><surname>Bradford</surname><given-names>Y.M.</given-names></name>, <name name-style="western"><surname>Brush</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Dahdul</surname><given-names>W.M.</given-names></name>, <name name-style="western"><surname>Dougall</surname><given-names>D.S.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Osumi-Sutherland</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ruttenberg</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sarntivijai</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The Cell Ontology 2016: enhanced content, modularization, and ontology interoperability</article-title>. <source>J. Biomed. Semant.</source><year>2016</year>; <volume>7</volume>:<fpage>44</fpage>.</mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Slyke</surname><given-names>C.E.</given-names></name>, <name name-style="western"><surname>Bradford</surname><given-names>Y.M.</given-names></name>, <name name-style="western"><surname>Howe</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Fashena</surname><given-names>D.S.</given-names></name>, <name name-style="western"><surname>Ramachandran</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ruzicka</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Staff</surname><given-names>ZFIN</given-names></name></person-group><article-title>Using ZFIN: Data types, organization, and retrieval</article-title>. <source>Methods Mol. Biol.</source><year>2018</year>; <volume>1757</volume>:<fpage>307</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">29761463</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grove</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cain</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W.J.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Howe</surname><given-names>K.L.</given-names></name>, <name name-style="western"><surname>Kishore</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Paulini</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Raciti</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Using WormBase: a genome biology resource for caenorhabditis elegans and related nematodes</article-title>. <source>Methods Mol. Biol.</source><year>2018</year>; <volume>1757</volume>:<fpage>399</fpage>–<lpage>470</lpage>.<pub-id pub-id-type="pmid">29761466</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Köhler</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vasilevsky</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Engelstad</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>McMurry</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Aymé</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Baynam</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bello</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Boerkoel</surname><given-names>C.F.</given-names></name>, <name name-style="western"><surname>Boycott</surname><given-names>K.M.</given-names></name><etal/></person-group><article-title>The human phenotype ontology in 2017</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D865</fpage>–<lpage>D876</lpage>.<pub-id pub-id-type="pmid">27899602</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
